Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma

Author(s):

Rebecca C. Abbott, Daniel J. Verdon, Fiona M. Gracey, Hannah E. Hughes-Parry, Melinda Iliopoulos, Katherine A. Watson, Matthias Mulazzani, Kylie Luong, Colleen D’Arcy, Lucy C. Sullivan, Ben R. Kiefel, Ryan S. Cross, Misty R. Jenkins

Details:

Clinical and Translational Immunology, Volume 10, Issue 5, 2021-01-01, Article number e1283

Article Link: Click here

Affiliations:

• University of Melbourne
• La Trobe University
• Royal Children's Hospital, Melbourne
• Walter and Eliza Hall Institute of Medical Research
• Department of Microbiology & Immunology
• Myrio Therapeutics